Search results for "Pau"

showing 10 items of 1636 documents

Gonadotropin Secretion in Eugonadotropic Human Males and Postmenopausal Females Under Long Term Application of a Potent Analog of Gonadotropin-Releas…

1978

Long-acting analogs are of special interest in long-term treatment with gonadotropin-releasing hormone (GnRH). However, inhibitory effects of agonist analogs on gonadotropin secretion or on reproductive processes have been observed in rats as well as in human males. Since these inhibitory effects seem to be dose-related, we checked the findings for d-Leu 6 -des-Gly 10 -GnRH-ethylamide within the dose range proposed by us for treatment. In six eugonadotropic human males, a significant decrease of luteinizing hormone and follicle-stimulating hormone responsiveness to a standard dose of GnRH and significant decrease of testosterone basal secretion were observed after 2 and 4weeks of subcutaneo…

AdultMaleAgonistendocrine systemmedicine.medical_specialtyTime Factorsmedicine.drug_classInjections SubcutaneousGonadotropin-releasing hormoneHuman MalesBiologyGonadotropin-Releasing HormoneBasal (phylogenetics)Internal medicinemedicineHumansTestosteroneAdministration IntranasalTestosteroneObstetrics and GynecologyLuteinizing HormoneGonadotropin secretionEndocrinologyReproductive MedicineFemaleFollicle Stimulating HormoneMenopauseLuteinizing hormonePituitary Hormone-Releasing Hormoneshormones hormone substitutes and hormone antagonistsHormoneFertility and Sterility
researchProduct

Hypogonadism-related symptoms: development and evaluation of an empirically derived self-rating instrument (HRS ‘Hypogonadism Related Symptom Scale’)

2009

While self-report screening instruments are highly sensitive to hypogonadism in the ageing male, they have lacked specificity as evidenced by low or absent correlations with testosterone. The purpose of this paper was to develop an economical and specific screening instrument for identifying hypogonadal ageing men. Based on a comprehensive study of physical, somatoform and affective complaints, sexual behaviour and function and hormonal parameters of 263 outpatients aged 40 years and above (M = 56.2; 40-84 years) recruited from six andrological outpatient departments in Germany, we identified those items correlating significantly with testosterone. By factor analyses, five factors were iden…

AdultMaleSenescenceAgingmedicine.medical_specialtymedicine.drug_classUrologyPhysical fitnessAndropauseStatistics NonparametricBody Mass IndexEndocrinologySurveys and QuestionnairesAndrogen deficiencyFlushingmedicineHumansTestosteroneSexual Dysfunctions PsychologicalAgedAged 80 and overGynecologybusiness.industryHypogonadismPatient SelectionTestosterone (patch)General MedicineMiddle AgedAndrogenmedicine.diseaseAgeingbusinessSexual functionBody mass indexClinical psychologyAndrologia
researchProduct

Cigarette smoking affects uterine receptiveness

2006

Background Cigarette smoking has long been known to have an effect on female fertility. The existence of an ovarian factor is clear when one considers that the mean age of the menopause is lower and IVF cycle outcome is worse in heavy smokers. The hypothesis of a concomitant uterine effect is raised by indirect evidence from in vitro and in vivo studies, but as yet, no direct evidence has been gained to confirm its existence. In this work, we analyse the association between smoking habit in oocyte recipients and cycle outcome. Methods We have retrospectively analysed the outcome of all oocyte donation cycles performed in our clinic from January 2002 to June 2005 from which there was availab…

AdultMalemedicine.medical_specialtyAdolescentPregnancy RateReproductive Techniques Assistedmedia_common.quotation_subjectFertilityAbortionPregnancyHumansMedicineRetrospective Studiesmedia_commonGynecologyPregnancyOocyte Donationbusiness.industrySmokingUterusRehabilitationObstetrics and GynecologyRetrospective cohort studymedicine.diseaseAbortion SpontaneousMenopausePregnancy rateReproductive MedicineSpainIn uteroFemalePregnancy MultiplebusinessBody mass indexHuman Reproduction
researchProduct

Bone Mineral Density and Long Term Exercise

1993

Evidence in human studies of the association of long term habitual exercise with bone mineral content (BMC) and density (BMD) largely comes from studies in athletes. In young adults, the highest BMC and BMD values have been found in strength and power-trained athletes, while endurance activities such as long distance running and swimming seem less effective with regard to peak bone density. Intensive endurance training may even be associated with amenorrhoea and decreased trabecular bone density in young females. However, after menopause female athletes show greater bone mass indicating that they do not share the accelerated decline in BMC observed in a nonathletic population. Middle-aged a…

AdultMalemusculoskeletal diseasesmedicine.medical_specialtyBone densitySports medicinePopulationPhysical Therapy Sports Therapy and RehabilitationPhysical exerciseRunningBone DensityEndurance trainingmedicineHumansOrthopedics and Sports MedicineeducationAmenorrheaExerciseSwimmingAgedBone mineraleducation.field_of_studybiologyAthletesbusiness.industrymusculoskeletal neural and ocular physiologyMiddle Agedmusculoskeletal systembiology.organism_classificationmedicine.diseasehumanitiesMenopauseCross-Sectional StudiesPhysical therapyFemaleMenopausebusinessSportsSports Medicine
researchProduct

Effect of continuous oestradiol-medroxyprogesterone administration on plasma lipids and lipoproteins

1991

Plasma lipids and lipoproteins were measured in 21 post-menopausal women after 4 and 8 months of continuous treatment with an orally administered combination of oestradiol and medroxyprogesterone acetate. The mean concentrations of cholesterol and low-density-lipoprotein (LDL) cholesterol were reduced by 12% (P less than 0.001) and 11% (P less than 0.01), respectively, after 4 months of treatment and by 9% (P less than 0.05) and 12% (P less than 0.05) after 8 months. The mean level of high-density-lipoprotein (HDL) cholesterol showed an initial fall of 5% (P less than 0.05) after 4 months and then increased by 13% (P less than 0.05) after 8 months of treatment. The plasma triglycerides leve…

AdultMedroxyprogesteronemedicine.medical_specialtymedicine.drug_classLipoproteinsMedroxyprogesteronemedicine.medical_treatmentGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundInternal medicinePlasma lipidsHumansMedicineMedroxyprogesterone acetateClinical significanceProspective StudiesEstradiolProgestogenbusiness.industryCholesterolEstrogen Replacement TherapyObstetrics and GynecologyMiddle AgedLipidsEndocrinologychemistryEstrogenDrug Therapy CombinationFemalelipids (amino acids peptides and proteins)Menopausebusinessmedicine.drugLipoproteinMaturitas
researchProduct

Electromyographic evaluation of synergist muscles of the pelvic floor muscle depending on the pelvis setting in menopausal women: A prospective obser…

2019

Background: Pelvic floor muscle (PFM) training is recommended to increase their strength and endurance. Muscles which act synergistically with PFM are taken into consideration in the therapeutic management of weakened PFM. Research question: how does electromyography activity of the synergists muscle to PFM change concerning pelvis position and does the greater bioelectric activity of synergist muscles affect PFM function? Methods: A prospective, observational study evaluating the surface electromyography (sEMG) activity of selected synergist muscles of the PFM depending on the orientation of the pelvis. One hundred thirty-one menopausal women registered for the study were screened for incl…

AdultPelvic tiltmedicine.medical_specialtySynergist musclesPostureBiophysicsElectromyographyPelvic Floor MusclePelvic floor muscle03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicineHumansOrthopedics and Sports MedicineProspective StudiesSurface electromyographyPelvismedicine.diagnostic_testElectromyographybusiness.industryRehabilitationPelvic Floor030229 sport sciencesCross-Sectional Studiesmedicine.anatomical_structureMultivariate AnalysisWomen's HealthFemaleObservational studyMenopausebusiness030217 neurology & neurosurgeryMuscle ContractionGait & Posture
researchProduct

Long-term consequences of polycystic ovary syndrome on cardiovascular risk

2009

Most available data suggest that the prevalence of cardiovascular diseases in women with polycystic ovary syndrome (PCOS) is smaller than expected based on risk calculations during fertile years; therefore, more studies are needed on long-term cardiovascular consequences. Evidence is accumulating that postmenopausal women with PCOS have an increased risk of cerebrovascular events and cardiovascular morbidity. These events are partially related to persisting hyperandrogenism but are mostly correlated with excessive body weight (mainly visceral obesity); this suggests that our best long-term strategy is to ensure that women with PCOS are informed about their high risk for metabolic and cardio…

AdultPolycystic ovary syndrome cardiovascular risk menopause eventsAgingPediatricsmedicine.medical_specialty10265 Clinic for Endocrinology and Diabetology610 Medicine & healthBody weightDiabetes ComplicationsRisk FactorsmedicineHumansCystObesityAgedAged 80 and overGynecologyPostmenopausal womenbusiness.industryHyperandrogenismObstetrics and Gynecology2729 Obstetrics and Gynecology2743 Reproductive MedicineMiddle Agedmedicine.diseasePolycystic ovaryMenopauseC-Reactive ProteinIncreased riskReproductive MedicineCardiovascular DiseasesAndrogensFemaleAdiponectinHyperandrogenismbusinessBiomarkersVisceral ObesityPolycystic Ovary Syndrome
researchProduct

Acute abdomen due to endometriosis in a premenopausal woman taking tamoxifen.

2003

Tamoxifen exhibits agonistic properties on the uterus. We describe a premenopausal woman who, while having tamoxifen due to a diagnosis of in situ ductal carcinoma, developed endometriosis requiring surgery.

AdultSelective Estrogen Receptor Modulatorsmedicine.medical_specialtyAntineoplastic Agents HormonalEndometriosisUterusEndometriosisBreast NeoplasmsCarcinomamedicineHumansskin and connective tissue diseasesGynecologybusiness.industryCarcinoma Ductal BreastObstetrics and GynecologyDuctal carcinomamedicine.diseaseAntiestrogenAbdominal PainOvarian CystsTamoxifenmedicine.anatomical_structureReproductive MedicinePremenopauseAcute abdomenAcute DiseaseFemalemedicine.symptombusinesshormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

Effects of Estrogen on Vascular Inflammation

2012

Objective— Our study aims to determine the role of time of menopause on vascular inflammation biomarkers and how it affects their modulation by estrogen and raloxifene in postmenopausal women. Methods and Results— Uterine arteries from 68 postmenopausal women were divided into 3 segments and cultured for 24 hours in tissue culture media containing 17β-estradiol (100 nmol/L), raloxifene (100 nmol/L), or vehicle. Assessment of arterial concentration of 13 inflammatory biomarkers was performed by multiplex immunobead-based assay. Aging per se has a positive correlation with the generation of several proinflammatory markers. Although short-term estradiol exposure correlates with lower expressi…

AdultVasculitisAgingmedicine.medical_specialtyTime Factorsmedicine.drug_classEstrogen receptorProinflammatory cytokinechemistry.chemical_compoundInternal medicinemedicineEstrogen Receptor betaHumansRaloxifeneEstrogen receptor betaAgedInterleukin-6business.industryEstrogen Receptor alphaEstrogensMiddle Agedmedicine.diseaseMenopauseVascular endothelial growth factorHormones esteroidesEndocrinologychemistryEstrogenRaloxifene HydrochlorideFemaleMenopauseCardiology and Cardiovascular MedicinebusinessEstrogen receptor alphahormones hormone substitutes and hormone antagonistsBiomarkersMenopausamedicine.drugArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Immunohistochemical characterization of endometriosis-associated smooth muscle cells in human peritoneal endometriotic lesions

2011

Background Smooth muscle cells (SMC) are common components of endometriotic lesions. SMC have been characterized previously in peritoneal, ovarian and deep infiltrating endometriotic lesions and adenomyosis. The aim of this retrospective study was to investigate the extent of differentiation in endometriosis-associated SMC (EMaSMC) in peritoneal endometriotic lesions. Methods We obtained biopsies from peritoneal endometriotic lesions (n = 60) and peritoneal sites distant from the endometriotic lesion (n = 60), as well as healthy peritoneum from patients without endometriosis (control tissue, n = 10). These controls were hysterectomy specimens from patients without endometriosis or adenomyos…

AdultendometriosisPathologymedicine.medical_specialtyBiopsyEndometriosisEstrogen receptorsmooth muscle metaplasiaPeritoneumRetrospective StudieProgesterone receptormedicinevasopressin receptorHumansMyocyteAdenomyosisEndometriosiOxytocin receptorRetrospective Studiesendometriosis; Oxytocin receptor; smooth muscle metaplasiaMyosin Heavy Chainsbusiness.industryRehabilitationMyosin Heavy ChainObstetrics and GynecologyCell DifferentiationMuscle SmoothMiddle Agedmusculoskeletal systemmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaImmunohistochemistrymedicine.anatomical_structureGene Expression RegulationPremenopauseReceptors EstrogenReproductive MedicineReceptors Oxytocinsmooth muscle actinImmunohistochemistryFemaleDesminPeritoneumReceptors ProgesteronebusinessHumanHuman Reproduction
researchProduct